This page lists the SEC filings reported by Citadel Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-25 | CITADEL ADVISORS LLC | MARINUS PHARMACEUTICALS, INC. | - | 0.0% | EDGAR |
| SC 13G | 2024-04-22 | CITADEL ADVISORS LLC | Protara Therapeutics, Inc. | - | 5.7% | EDGAR |
| SC 13G | 2024-03-25 | CITADEL ADVISORS LLC | REV Group, Inc. | - | 5.1% | EDGAR |
| SC 13G | 2024-03-22 | CITADEL ADVISORS LLC | CUMMINS INC | - | 0.1% | EDGAR |
| SC 13G | 2024-03-18 | CITADEL ADVISORS LLC | Atara Biotherapeutics, Inc. | - | 6.4% | EDGAR |
| SC 13G | 2024-02-23 | CITADEL ADVISORS LLC | Helix Acquisition Corp. II | - | 7.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Acropolis Infrastructure Acquisition Corp. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Apollo Strategic Growth Capital II | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Artemis Strategic Investment Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Decibel Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Forbion European Acquisition Corp. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Khosla Ventures Acquisition Co. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Acrivon Therapeutics, Inc. | - | 7.4% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Northern Star Investment Corp. II | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Project Energy Reimagined Acquisition Corp. | - | 1.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | SPRUCE BIOSCIENCES, INC. | - | 0.2% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Tourmaline Bio, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Ventyx Biosciences, Inc. | - | 5.9% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Vera Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Vigil Neuroscience, Inc. | - | 6.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.